Inhibition of Breast Cancer Metastasis Via PITPNM3 by Pachymic Acid

被引：32
作者：
Hong, Ri [1 ]
Shen, Min-He [2 ]
Xie, Xiao-Hong [1 ]
Ruan, Shan-Ming [2 ]
机构：
[1] Zhejiang Chinese Med Univ, Sch Clin Med 1, Dept Breast, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Clin Med 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2012年 / 13卷 / 05期
关键词：
Breast cancer; metastasis; MDA-MB-231; PITPNM3; pachymic acid; PORIA-COCOS; CCL18; MACROPHAGES; EXPRESSION; BONE;
D O I：
10.7314/APJCP.2012.13.5.1877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer metastasis is the most common cause of cancer-related death in women. Thus, seeking targets of breast tumor cells is an attractive goal towards improving clinical treatment. The present study showed that CCL18 from tumor-associated macrophages could promote breast cancer metastasis via PITPNM3. In addition, we found that pachymic acid (PA) could dose-dependently inhibit migration and invasion of MDA-MB-231cells, with or without rCCL18 stimulation. Furthermore, evidence was obtained that PA could suppress the phosphorylation of PITPNM3 and the combination of CCL18 and PITPNM3. Therefore, we speculate that PA could inhibit breast cancer metastasis via PITPNM3.
引用
收藏
页码：1877 / 1880
页数：4
相关论文
共 50 条
[21]   Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo [J].
Jia, Xiaoqing ;
Cheng, Jingyi ;
Shen, Zhenzhou ;
Shao, Zhimin ;
Liu, Guangyu .
MOLECULAR MEDICINE REPORTS, 2018, 17 (04) :5470-5476
[22]   MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer [J].
Lee, Jin-Won ;
Guan, Wei ;
Han, Sanghak ;
Hong, Deok-Ki ;
Kim, Lee-Su ;
Kim, Haesung .
CANCER SCIENCE, 2018, 109 (05) :1404-1413
[23]   RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells [J].
Yang, Yuan ;
Quan, Lingli ;
Ling, Ye .
ONCOLOGY RESEARCH, 2018, 26 (01) :9-15
[24]   4-Methyl-3-nitro-benzoic acid, a migration inhibitor, prevents breast cancer metastasis in SCID mice [J].
Guo, Hua ;
Li, Menghui ;
Chen, Peng ;
Blake, David J. ;
Kong, Xiaoni ;
Hao, Xishan ;
Niu, Ruifang ;
Zhang, Ning .
CANCER LETTERS, 2011, 305 (01) :69-75
[25]   Dissecting Breast Cancer Circulating Tumor Cells Competence via Modelling Metastasis in Zebrafish [J].
Martinez-Pena, Ines ;
Hurtado, Pablo ;
Carmona-Ule, Nuria ;
Abuin, Carmen ;
Belen Davila-Ibanez, Ana ;
Sanchez, Laura ;
Abal, Miguel ;
Chaachou, Anas ;
Hernandez-Losa, Javier ;
Cajal, Santiago Ramon Y. ;
Lopez-Lopez, Rafael ;
Pineiro, Roberto .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
[26]   CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN [J].
Li, Weiwei ;
Lei, Ting ;
Song, Xiaoyu ;
Deng, Chun ;
Lu, Jingrun ;
Zhang, Wenwu ;
Kuang, Zhenzhan ;
He, Yongyin ;
Zhou, Quan ;
Luo, Zhaoxun ;
Mo, Fei ;
Yang, Hanlin ;
Hang, Jianfeng ;
Xiao, Bin ;
Li, Linhai .
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (06) :588-598
[27]   Filamin A Is a Potential Driver of Breast Cancer Metastasis via Regulation of MMP-1 [J].
Zhou, Jie ;
Wu, Lvying ;
Xu, Pengyan ;
Li, Yue ;
Ji, Zhiliang ;
Kang, Xinmei .
FRONTIERS IN ONCOLOGY, 2022, 12
[28]   Cystathionine-γ-lyase promotes the metastasis of breast cancer via the VEGF signaling pathway [J].
Wang, Lupeng ;
Shi, Haimei ;
Liu, Ya ;
Zhang, Weiyuan ;
Duan, Xiaofang ;
Li, Ming ;
Shi, Xiaoyan ;
Wang, Tianxiao .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (02) :473-487
[29]   SKA2 mediates invasion and metastasis in human breast cancer via EMT [J].
Ren, Zhouhui ;
Yang, Tong ;
Zhang, Pingping ;
Liu, Kaitai ;
Liu, Weihong ;
Wang, Ping .
MOLECULAR MEDICINE REPORTS, 2019, 19 (01) :515-523
[30]   The effect of ELOVL6 fatty acid elongase inhibition on the expression of genes associated with the metastasis of breast cancer [J].
G. S. Zakharova ;
A. A. Poloznikov ;
L. A. Astakhova ;
M. P. Raigorodskaya ;
Z. B. Khesina ;
K. A. Fomicheva ;
A. K. Buryak ;
B. Ya. Alekseev .
Russian Chemical Bulletin, 2018, 67 :2307-2315
12345